GlassScriptPhysician profile
Anna M Squires
NPI 1063010452
$1,549.75
in general payments reported to CMS, 2019-2025
13 companies · $501 in 2025
The $501 reported for 2025 was more than what 77% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $69.61 · 2022: $148 · 2023: $294 · 2024: $536 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,331.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $469.19 | 2022-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $443.26 | 2021-2024 | |
| Pfizer INC. | $242.45 | 2023-2025 | |
| Edwards Lifesciences Corporation | $134.32 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novo Nordisk INC | $84.51 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $33.86 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $31.88 | 2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $29.89 | 2024 | Assure Wcd |
| Teleflex LLC | $21.78 | 2023 | Guideliner |
| Medtronic, INC. | $15.29 | 2022 | |
| Philips North America LLC | $15.20 | 2024 | (Ck4) Mcot |
| Janssen Pharmaceuticals, INC | $14.56 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Squires listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.